Guided Therapeutics (GTHP) News Today → This unknown company solves the biggest issue with AI (From Manward Press) (Ad) Free GTHP Stock Alerts $0.08 -0.02 (-20.00%) (As of 05/15/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 2, 2024 | msn.comG1 Therapeutics, Inc. (NASDAQ:GTHX) Q1 2024 Earnings Call TranscriptFebruary 20, 2024 | finance.yahoo.comLeading Cervical Cancer Doctors Support Approval of LuViva in China Based on Preliminary Review of Clinical Trial ResultsFebruary 20, 2024 | businesswire.comLeading Cervical Cancer Doctors Support Approval of LuViva in China Based on Preliminary Review of Clinical Trial ResultsNovember 20, 2023 | thestreet.comGuided Therapeutics IncNovember 20, 2023 | finance.yahoo.comGuided Therapeutics Announces Completion of Clinical Study for Chinese Regulatory ApprovalJuly 18, 2023 | seekingalpha.comGTHPFebruary 17, 2023 | abcnews.go.com'It was a trap': Video shows American volunteer likely killed by guided missile in 'deliberate' Russian attackNovember 9, 2022 | finance.yahoo.comGuided Therapeutics Provides Update of Significant Progress in Chinese Clinical Study for Marketing Approval of the LuViva Advanced Cervical ScanJuly 20, 2022 | finance.yahoo.comGuided Therapeutics Receives Institutional Review Board Approval to Start Clinical Study for FDA Approval of the LuViva® Advanced Cervical ScanJune 9, 2022 | finance.yahoo.comImpel Pharmaceuticals to Present Trudhesa® Data at the 64th Annual Meeting of the American Headache SocietyMay 18, 2022 | stockhouse.comOlive Resource Capital Announces Agreement to Acquire C$2.5M Portfolio of AssetsMarch 31, 2022 | finance.yahoo.comGuided Therapeutics Announces Testing Completion of First 150 Patients in Chinese Clinical Study and Receives Milestone Payment of $177,740November 17, 2021 | finance.yahoo.comGuided Therapeutics Announces Start of Chinese Clinical Trial for Approval to Market and Sell LuViva in ChinaOctober 5, 2021 | finance.yahoo.comGuided Therapeutics Ships LuViva Devices to China for Start of Clinical Trial; Receives Additional $100,000 Payment Get Guided Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GTHP and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon Musk’s Next Move Will Disrupt AI Forever (Ad)A revolutionary venture that is set to get rolled out by May 16. One well-connected Silicon Valley VC has uncovered a way for anybody to claim a stake in "Elon Musk's AI 2.0" with as little as $100. Get all the information here. GTHP Media Mentions By Week GTHP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GTHP News Sentiment▼1.190.55▲Average Medical News Sentiment GTHP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GTHP Articles This Week▼30▲GTHP Articles Average Week Get Guided Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GTHP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ENDRA Life Sciences News Today Nuwellis News Today Micron Solutions News Today Helius Medical Technologies News Today Tivic Health Systems News Today BioSig Technologies News Today QT Imaging News Today Silo Pharma News Today Synaptogenix News Today NexImmune News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:GTHP) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsTop 5 AI Stocks to Buy for 2024Market Moving TrendsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportPharma Giant Makes Deal with a "Drug Smuggler"Behind the MarketsTop 5 Tech Stocks to Buy for 2024Daily Market Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guided Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
